A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN
Clinical trial NCT04306510 · TERMINATED
Trial details
- NCT number
- NCT04306510
- Sponsor
- Akcea Therapeutics
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-21
- Primary completion
- 2024-03-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.